Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer

NCT00279448 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

9779

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: exemestane
DRUG: tamoxifen

Sponsor

Pfizer